Search Results - "Cheng, Judy"

Refine Results
  1. 1

    Sodium-Glucose Cotransporter 2 Inhibitors Among Heart Failure With Mildly Reduced and Preserved Ejection Fraction by Cheng, Judy W. M., Colucci, Vincent, Kalus, James S., Spinler, Sarah A.

    Published in Annals of Pharmacotherapy (01-11-2023)
    “…Objective: Results from large placebo-controlled randomized trials in patients with heart failure with mid-range ejection fraction (HFmrEF) and HF with…”
    Get full text
    Book Review Journal Article
  2. 2

    Cardiovascular Pharmacology in the Time of COVID-19: A Focus on Angiotensin-Converting Enzyme 2 by Buckley, Leo F., Cheng, Judy W. M., Desai, Akshay

    Published in Journal of cardiovascular pharmacology (01-06-2020)
    “…Coronavirus disease-2019 (COVID-19) has emerged as a pandemic affecting millions of adults. Severe acute respiratory syndrome coronavirus-2019 (SARS-CoV-2),…”
    Get full text
    Journal Article
  3. 3

    Azilsartan Medoxomil: A New Angiotensin Receptor Blocker by Zaiken, Kathy, PharmD, Cheng, Judy W.M., PharmD, MPH, FCCP, BCPS

    Published in Clinical therapeutics (01-11-2011)
    “…Abstract Background Azilsartan medoxomil is an angiotensin receptor blocker, approved on February 25, 2011 by the US Food and Drug Administration (FDA) for…”
    Get full text
    Journal Article
  4. 4

    Prognostic variables in high-risk cutaneous squamous cell carcinoma: a review by Cheng, Judy, Yan, Shaofeng

    Published in Journal of cutaneous pathology (01-11-2016)
    “…Cutaneous squamous cell carcinoma (SCC) is a growing public health problem in the United States. A subset of high‐risk SCC exhibits a more aggressive clinical…”
    Get full text
    Journal Article
  5. 5

    Direct oral anticoagulants in patients with atrial fibrillation and renal impairment, extremes in weight, or advanced age by Buckley, Leo F., Rybak, Eva, Aldemerdash, Ahmed, Cheng, Judy W.M., Fanikos, John

    Published in Clinical cardiology (Mahwah, N.J.) (01-01-2017)
    “…A growing number of patients with an indication for stroke prevention in atrial fibrillation have kidney‐, age‐, or weight‐related alterations in…”
    Get full text
    Journal Article
  6. 6

    Botulinum Toxin Injections for Masseter Reduction in East Asians by Cheng, Judy, Hsu, Sarah H, McGee, Jean S

    Published in Dermatologic surgery (01-04-2019)
    “…BACKGROUNDCultural ideals for a slimmer face have led to an upsurge in interest in facial contouring among East Asians. Although surgical resection has…”
    Get full text
    Journal Article
  7. 7

    Focused Updates: SGLT2 Inhibitors in Patients With Heart Failure and/or Chronic Kidney Disease by Cheng, Judy W. M., Colucci, Vincent, Kalus, James S., Spinler, Sarah A.

    Published in The Annals of pharmacotherapy (01-02-2021)
    “…Sodium-glucose cotransporter (SGLT2) inhibitors have demonstrated cardiovascular (CV) benefits in large-scale clinical trials of people who have type 2…”
    Get full text
    Journal Article
  8. 8

    Current perspectives on the role of the pharmacist in heart failure management by Cheng, Judy Wm

    Published in Integrated pharmacy research and practice (01-01-2018)
    “…Pharmacists play an important role within a multidisciplinary health care team in the care of patients with heart failure (HF). It has been evaluated and…”
    Get full text
    Journal Article
  9. 9

    Nebivolol: A third-generation β-blocker for hypertension by Cheng, Judy W.M., BS, PharmD, MPH, FCCP, BCPS

    Published in Clinical therapeutics (01-03-2009)
    “…Abstract Background: Nebivolol is a third-generation β1 -selective β-blocker that is approved for the treatment of hypertension. Objective: This article…”
    Get full text
    Journal Article
  10. 10
  11. 11

    METALLICITY GRADIENTS IN THE MILKY WAY DISK AS OBSERVED BY THE SEGUE SURVEY by CHENG, Judy Y, ROCKOSI, Constance M, MORRISON, Heather L, SCHÖNRICH, Ralph A, YOUNG SUN LEE, BEERS, Timothy C, BIZYAEV, Dmitry, PAN, Kaike, SCHNEIDER, Donald P

    Published in The Astrophysical journal (20-02-2012)
    “…The observed radial and vertical metallicity distribution of old stars in the Milky Way disk provides a powerful constraint on the chemical enrichment and…”
    Get full text
    Journal Article
  12. 12

    Impact of selective platelet inhibition in reducing cardiovascular risk - role of vorapaxar by Cheng, Judy Wm

    Published in Vascular health and risk management (01-01-2016)
    “…This article reviews the pharmacology, clinical efficacy, and safety of vorapaxar in reducing cardiovascular risk. Vorapaxar is a tricyclic himbacine-derived…”
    Get full text
    Journal Article
  13. 13

    Dabigatran Etexilate: An Oral Direct Thrombin Inhibitor for the Management of Thromboembolic Disorders by Cheng, Judy W.M., BS, PharmD, MPH, FCCP, BCPS, Vu, Huyen

    Published in Clinical therapeutics (01-04-2012)
    “…Abstract Background Until recently, warfarin was the only oral anticoagulant available in the United States. Its narrow therapeutic index, interpatient…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Managing Diabetes and Preventing Heart Disease: Have We Found a Safe and Effective Agent? by Cheng, Judy W. M., Colucci, Vincent J., Kalus, James S., Spinler, Sarah A.

    Published in Annals of Pharmacotherapy (01-05-2019)
    “…Objective: While improving glycemic control with antihyperglycemics has been demonstrated to reduce microvascular complications, the benefits of reduction in…”
    Get full text
    Book Review Journal Article
  16. 16
  17. 17
  18. 18
  19. 19

    Activin A targets extrasynaptic NMDA receptors to ameliorate neuronal and behavioral deficits in a mouse model of Huntington disease by Nassrallah, Wissam B, Ramandi, Daniel, Cheng, Judy, Oh, Jean, Mackay, James, Sepers, Marja D, Lau, David, Bading, Hilmar, Raymond, Lynn A

    Published in Neurobiology of disease (01-12-2023)
    “…Cortical-striatal synaptic dysfunction, including enhanced toxic signaling by extrasynaptic N-methyl-d-aspartate receptors (eNMDARs), precedes…”
    Get full text
    Journal Article
  20. 20

    Aliskiren: Renin inhibitor for hypertension management by Cheng, Judy W.M., BS, PharmD, MPH, FCCP, BCPS

    Published in Clinical therapeutics (2008)
    “…Abstract Background: The renin-angiotensin-aldosterone system (RAAS) has long been recognized to play a significant role in hypertension pathophysiology…”
    Get full text
    Journal Article